Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M201056200 on February 12, 2002

J. Biol. Chem., Vol. 277, Issue 17, 14764-14770, April 26, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/17/14764    most recent
M201056200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Broschat, K. O.
Right arrow Articles by Kasten, T. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Broschat, K. O.
Right arrow Articles by Kasten, T. P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Kinetic Characterization of Human Glutamine-fructose-6-phosphate Amidotransferase I
POTENT FEEDBACK INHIBITION BY GLUCOSAMINE 6-PHOSPHATE*

Kay O. BroschatDagger §, Christine GorkaDagger , Jimmy D. Page, Cynthia L. Martin-Berger, Michael S. Davies||, Horng-chih Huang**, Eric A. GulveDagger , William J. Salsgiver||, and Thomas P. Kasten||

From the Dagger  Cardiovascular & Metabolic Disesases, Pharmacia Corporation, St. Louis, Missouri 63167,  Discovery Biology, Pharmacia Corporation, Skokie, Illinois 60077, and || Biochemistry & Molecular Biology and ** Discovery Chemistry, Pharmacia Corporation, Chesterfield, Missouri 63198

Glutamine-fructose-6-phosphate amidotransferase (GFAT) catalyzes the first committed step in the pathway for biosynthesis of hexosamines in mammals. A member of the N-terminal nucleophile class of amidotransferases, GFAT transfers the amino group from the L-glutamine amide to D-fructose 6-phosphate, producing glutamic acid and glucosamine 6-phosphate. The kinetic constants reported previously for mammalian GFAT implicate a relatively low affinity for the acceptor substrate, fructose 6-phosphate (Fru-6-P, Km 0.2-1 mM). Utilizing a new sensitive assay that measures the production of glucosamine 6-phosphate (GlcN-6-P), purified recombinant human GFAT1 (hGFAT1) exhibited a Km for Fru-6-P of 7 µM, and was highly sensitive to product inhibition by GlcN-6-P. In a second assay method that measures the stimulation of glutaminase activity, a Kd of 2 µM was measured for Fru-6-P binding to hGFAT1. Further, we report that the product, GlcN-6-P, is a potent competitive inhibitor for the Fru-6-P site, with a Ki measured of 6 µM. Unlike other members of the amidotransferase family, where glutamate production is loosely coupled to amide transfer, we have demonstrated that hGFAT1 production of glutamate and GlcN-6-P are strictly coupled in the absence of inhibitors. Similar to other amidotransferases, competitive inhibitors that bind at the synthase site may inhibit the synthase activity without inhibiting the glutaminase activity at the hydrolase domain. GlcN-6-P, for example, inhibited the transfer reaction while fully activating the glutaminase activity at the hydrolase domain. Inhibition of hGFAT1 by the end product of the pathway, UDP-GlcNAc, was competitive with a Ki of 4 µM. These data suggest that hGFAT1 is fully active at physiological levels of Fru-6-P and may be regulated by its product GlcN-6-P in addition to the pathway end product, UDP-GlcNAc.


* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Cardiovascular and Metabolic Diseases, Pharmacia Corp. T2M, 800 N. Lindbergh Blvd., St. Louis, MO 63167. Tel.: 314-694-8988; Fax: 314-694-5216; E-mail: kay.o.broschat@pharmacia.com.


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
GENES CELLSHome page
S. Eguchi, N. Oshiro, T. Miyamoto, K.-i. Yoshino, S. Okamoto, T. Ono, U. Kikkawa, and K. Yonezawa
AMP-activated protein kinase phosphorylates glutamine : fructose-6-phosphate amidotransferase 1 at Ser243 to modulate its enzymatic activity.
Genes Cells, February 1, 2009; 14(2): 179 - 189.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
K. S Lau and J. W Dennis
N-Glycans in cancer progression
Glycobiology, October 1, 2008; 18(10): 750 - 760.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Grigorian, S.-U. Lee, W. Tian, I.-J. Chen, G. Gao, R. Mendelsohn, J. W. Dennis, and M. Demetriou
Control of T Cell-mediated Autoimmunity by Metabolite Flux to N-Glycan Biosynthesis
J. Biol. Chem., July 6, 2007; 282(27): 20027 - 20035.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
T. Tanaka, F. Takahashi, T. Fukui, S. Fujiwara, H. Atomi, and T. Imanaka
Characterization of a Novel Glucosamine-6-Phosphate Deaminase from a Hyperthermophilic Archaeon
J. Bacteriol., October 15, 2005; 187(20): 7038 - 7044.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Marshall, O. Nadeau, and K. Yamasaki
Glucosamine-induced Activation of Glycogen Biosynthesis in Isolated Adipocytes: EVIDENCE FOR A RAPID ALLOSTERIC CONTROL MECHANISM WITHIN THE HEXOSAMINE BIOSYNTHESIS PATHWAY
J. Biol. Chem., March 25, 2005; 280(12): 11018 - 11024.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Hu, L. Riesland, A. J. Paterson, and J. E. Kudlow
Phosphorylation of Mouse Glutamine-Fructose-6-phosphate Amidotransferase 2 (GFAT2) by cAMP-dependent Protein Kinase Increases the Enzyme Activity
J. Biol. Chem., July 16, 2004; 279(29): 29988 - 29993.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. J. Vocadlo, H. C. Hang, E.-J. Kim, J. A. Hanover, and C. R. Bertozzi
A chemical approach for identifying O-GlcNAc-modified proteins in cells
PNAS, August 5, 2003; 100(16): 9116 - 9121.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. Weigert, K. Klopfer, C. Kausch, K. Brodbeck, M. Stumvoll, H. U. Haring, and E. D. Schleicher
Palmitate-Induced Activation of the Hexosamine Pathway in Human Myotubes: Increased Expression of Glutamine:Fructose-6-Phosphate Aminotransferase
Diabetes, March 1, 2003; 52(3): 650 - 656.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement